April 21, 2011

Tempur-Pedic Reports Record First Quarter 2011 Sales and Earnings


-- Reports EPS of $0.68

LEXINGTON, Ky., April 21, 2011 /PRNewswire/ -- Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announced financial results for the first quarter ended March 31, 2011. The Company also confirmed financial guidance for 2011.

Financial Summary

  • Earnings per diluted share (EPS) were $0.68 in the first quarter of 2011 as compared to $0.44 in the first quarter of 2010. The Company reported net income of $48.3 million in the first quarter of 2011 as compared to $33.1 million in the first quarter of 2010.

  • Net sales increased 28% to $325.8 million in the first quarter of 2011 from $253.9 million in the first quarter of 2010. Net sales in the North American segment increased 37%, while International segment net sales increased 11%. On a constant currency basis, International segment net sales increased 8%.  

  • Mattress sales increased 29% globally. Mattress sales increased 36% in the North American segment and 12% in the International segment. On a constant currency basis, International mattress sales increased 10%. Pillow sales increased 13% globally. Pillow sales increased 24% in North America and 3% Internationally. On a constant currency basis, International pillow sales were unchanged.

  • Gross profit margin was 52.3% as compared to 49.2% in the first quarter of 2010. The gross profit margin increased as a result of improved efficiencies in manufacturing, favorable product mix and fixed cost leverage related to higher production volumes, partially offset by geographic mix.

  • Operating profit margin was 23.1% as compared to 20.6% in the first quarter of 2010. The increase was driven by improved gross profit margin partially offset by increased marketing investments.

  • The Company generated $55.7 million of operating cash flow in the first quarter of 2011 as compared to $23.3 million in the first quarter of 2010.  

Share Repurchase Program

During the first quarter of 2011, the Company purchased 1.32 million shares of its common stock at an average price of $47.35 for a total cost of $62.5 million. As of March 31, 2011, the Company had $137.5 million available under its existing share repurchase authorization.

Financial Guidance

The Company confirmed its full year 2011 guidance for net sales and earnings per share. It currently expects net sales for 2011 to range from $1.31 billion to $1.36 billion. It currently expects EPS for 2011 to range from $2.80 to $2.95 per diluted share. The Company noted its expectations are based on information available at the time of this release, and are subject to changing conditions, many of which are outside the Company's control. The Company noted its EPS guidance does not assume any benefit from a potential further reduction in shares outstanding related to its share repurchase program.

Conference Call Information

Tempur-Pedic International will host a live conference call to discuss financial results today, April 21, 2011 at 8:00 a.m. Eastern Time. The dial-in number for the conference call is 800-850-2903. The dial-in number for international callers is 224-357-2399. The call is also being webcast and can be accessed on the investor relations section of the Company's website, http://www.tempurpedic.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days.

Forward-looking Statements

This release contains "forward-looking statements," within the meaning of federal securities laws, which include information concerning one or more of the Company's plans, objectives, goals, strategies, and other information that is not historical information. When used in this release, the words "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements include, without limitation, statements relating to the Company's expectations for building on its 2010 performance in 2011, and for net sales and earnings per share for 2011. All forward looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct.

There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. These risk factors include general economic, financial  and industry conditions, particularly in the retail sector, as well as consumer confidence and the availability of consumer financing; uncertainties arising from global events; the effects of changes in foreign exchange rates on the Company's reported earnings; consumer acceptance of the Company's products; industry competition; the efficiency and effectiveness of the Company's advertising campaigns and other marketing programs; the Company's ability to increase sales productivity within existing retail accounts and to further penetrate the Company's retail channel, including the timing of opening or expanding within large retail accounts; the Company's ability to expand brand awareness, distribution and new products in international markets; the Company's ability to continuously improve and expand its product line, maintain efficient, timely and cost-effective production and delivery of its products, and manage its growth; changes in foreign tax rates, including the ability to utilize tax loss carry forwards; and rising commodity costs. Additional information concerning these and other risks and uncertainties are discussed in the Company's filings with the Securities and Exchange Commission, including without limitation the Company's annual report on Form 10-K under the headings "Special Note Regarding Forward-Looking Statements" and "Risk Factors." Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements for any reason, including to reflect events or circumstances after the date on which such statements are made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

About the Company

Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes mattresses and pillows made from its proprietary TEMPUR(R) pressure-relieving material. It is the worldwide leader in premium and specialty sleep. The Company is focused on developing, manufacturing and marketing advanced sleep surfaces that help improve the quality of life for people around the world. The Company's products are currently sold in over 80 countries under the TEMPUR(R) and Tempur-Pedic(R) brand names. World headquarters for Tempur-Pedic International is in Lexington, KY. For more information, visit http://www.tempurpedic.com or call 800-805-3635.

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(In thousands, except per common share amounts)



Three Months Ended




March 31,





2011




2010


Chg%


Net sales

$

325,838



$

253,889


28%


Cost of sales


155,528




129,080














Gross profit


170,310




124,809


36%












Selling and marketing expenses


64,370




46,231




General, administrative and other expenses


30,660




26,288














Operating income


75,280




52,290


44%












Other expense, net:










Interest expense, net


(2,539)




(3,189)




Other (expense)/income, net


(603)




68




Total other expense


(3,142)




(3,121)














Income before income taxes


72,138




49,169


47%


Income tax provision


23,878




16,021




Net income


48,260




33,148


46%












Earnings per common share:










Basic

$

0.70



$

0.45




Diluted

$

0.68



$

0.44




Weighted average common shares outstanding:










Basic


68,565




73,313




Diluted


70,871




75,678







TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands)



March 31,


December 31,



2011


2010


ASSETS
















Current Assets:








    Cash and cash equivalents

$

59,360



$

53,623


    Accounts receivable, net


134,407




115,630


    Inventories


71,716




69,856


    Prepaid expenses and other current assets


22,932




18,646


    Deferred income taxes


12,903




13,725


Total Current Assets


301,318




271,480










    Property, plant and equipment, net


161,076




159,807


    Goodwill


213,212




212,468


    Other intangible assets, net


67,737




68,745


    Other non-current assets


3,169




3,503


Total Assets

$

746,512



$

716,003










LIABILITIES AND STOCKHOLDERS' EQUITY
















Current Liabilities:








    Accounts payable

$

65,332



$

48,288


    Accrued expenses and other current liabilities


81,275




85,469


    Income taxes payable


22,423




12,477


Total Current Liabilities


169,030




146,234










    Long-term debt


395,000




407,000


    Deferred income taxes


30,866




32,315


    Other non-current liabilities


4,434




4,421


Total Liabilities


599,330




589,970










Total Stockholders' Equity


147,182




126,033










Total Liabilities and Stockholders' Equity

$

746,512



$

716,003













TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)



Three Months Ended


March 31,



2011




2010


CASH FLOWS FROM OPERATING ACTIVITIES:








Net income

$

48,260



$

33,148


Adjustments to reconcile net income to net cash provided by operating activities:








         Depreciation and amortization


8,341




7,585


         Amortization of stock-based compensation


2,729




2,411


         Amortization of deferred financing costs


173




173


         Bad debt expense


670




576


         Deferred income taxes


(962)




1,776


         Foreign currency adjustments and other


(442)




(844)


         Changes in operating assets and liabilities


(3,044)




(21,505)


Net cash provided by operating activities


55,725




23,320










CASH FLOWS FROM INVESTING ACTIVITIES:








Purchases of property, plant and equipment and other


(5,044)




(2,758)


Net cash used by investing activities


(5,044)




(2,758)










CASH FLOWS FROM FINANCING ACTIVITIES:








Proceeds from long-term revolving credit facility


11,000




129,336


Repayments of long-term revolving credit facility


(23,000)




(33,749)


      Proceeds from issuance of common stock


16,717




8,308


Excess tax benefit from stock based compensation


7,953




1,289


Treasury shares repurchased


(61,107)




(100,000)


Net cash (used) provided by financing activities


(48,437)




5,184










NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS


3,493




(1,366)










Increase in cash and cash equivalents


5,737




24,380










CASH AND CASH EQUIVALENTS, beginning of period


53,623




14,042










CASH AND CASH EQUIVALENTS, end of period

$

59,360



$

38,422













Summary of Channel Sales

The Company generates sales through four distribution channels: retail, direct, healthcare and third party.  The retail channel sells to furniture, specialty and department stores globally.  The direct channel sells directly to consumers and through company-owned stores.  The healthcare channel sells to hospitals, nursing homes, healthcare professionals and medical retailers.  The third party channel sells to distributors in countries where Tempur-Pedic International does not operate its own distribution company.

In our International segment certain of our subsidiaries sell directly through company-owned stores. Until recently these sales have been an immaterial amount and were reported through our Retail channel. In 2011, and consistent with our growth initiatives, we are reporting company-owned stores in the International segment within the Direct channel. Prior period amounts have been reclassified to conform to the 2011 presentation of Net sales, by channel and by segment. These changes do not affect previously reported International segment Net sales totals.

On April 1, 2010, the Company purchased its third party distributor in Canada. Accordingly, net sales in the Canadian market are reported in the appropriate channels within the North American segment. As Canada represented essentially all sales through the North American third party channel, the Company no longer reports third party sales in this segment.

The following table highlights net sales information, by channel and by segment:


(In thousands)


CONSOLIDATED

NORTH AMERICA

INTERNATIONAL


Three Months Ended

Three Months Ended

Three Months Ended


March 31,

March 31,

March 31,


2011

2010

2011

2010

2011

2010














Retail

$

284,430

$

211,899

$

208,148

$

143,217

$

76,282

$

68,682

Direct


23,190


17,455


17,960


14,555


5,230


2,900

Healthcare


8,997


9,898


2,895


3,438


6,102


6,460

Third Party


9,221


14,637


-


5,343


9,221


9,294


$

325,838

$

253,889

$

229,003

$

166,553

$

96,835

$

87,336




Summary of Product Sales

The following table highlights net sales information, by product and by segment:


(In thousands)


CONSOLIDATED

NORTH AMERICA

INTERNATIONAL


Three Months Ended

Three Months Ended

Three Months Ended


March 31,

March 31,

March 31,


2011

2010

2011

2010

2011

2010














Mattresses

$

217,336

$

169,071

$

159,445

$

117,386

$

57,891

$

51,685

Pillows


34,712


30,746


17,589


14,129


17,123


16,617

Other


73,790


54,072


51,969


35,038


21,821


19,034


$

325,838

$

253,889

$

229,003

$

166,553

$

96,835

$

87,336




TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

Reconciliation of Adjusted EBITDA to Net Income and Funded debt to Total debt

Non-GAAP Measures

(In thousands)



The Company provides information regarding Adjusted EBITDA and Funded debt which are not recognized terms under U.S. GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. A reconciliation of Adjusted EBITDA to the Company's Net income and a reconciliation of Funded debt to Total debt are provided below. Management believes that the use of Adjusted EBITDA and Funded debt provides investors with useful information with respect to the terms of the Company's credit facility.

Reconciliation of Net income to Adjusted EBITDA

The following table sets forth the reconciliation of the Company's reported Net income to the calculation of Adjusted EBITDA for each of the three months ended June 30, 2010, September 30, 2010, December 31, 2010 and March 31, 2011, as well as the twelve months ended March 31, 2011:




Three Months Ended

Twelve Months Ended



June 30,   2010

September 30, 2010

December 31, 2010

March 31, 2011

March 31, 2011








GAAP Net income

$

33,506

$              44,198

$          46,292

$     48,260

$           172,256

Plus:







  Interest expense


3,786

4,068

3,458

2,539

13,851

  Income taxes


16,485

19,324

21,890

23,878

81,577

  Depreciation  &  

  Amortization


11,049

10,778

12,146

11,070

45,043

  Other (1)


202

202








Adjusted EBITDA

$

65,028

$              78,368

$          83,786

$     85,747

$           312,929




(1) Includes professional costs incurred in connection with the acquisition of the Company's Canadian distributor, which closed on April 1, 2010. In accordance with the Company's credit facility, this amount is excluded from the calculation of Adjusted EBITDA for purposes of calculating compliance with the ratio of Funded debt to Adjusted EBITDA.

Reconciliation of Funded debt to Total debt

The following table sets forth the reconciliation of the Company's reported Total debt to the calculation of Funded debt as of March 31, 2011:




As of



March 31, 2011




GAAP basis Total debt

$

395,000

Plus:



  Letters of credit outstanding


13,561

Funded debt

$

408,561





Calculation of Funded debt to Adjusted EBITDA



As of



March 31, 2011




Funded debt

$

408,561

Adjusted EBITDA


312,929



1.31 times




SOURCE Tempur-Pedic International Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Tempur Sealy International, Inc.